The preparation of
two polyarginine conjugates of the complex Os(II)
[bis-(4′-(4-carboxyphenyl)-2,2′:6′,2″-terpyridine)]
[Os-(R
n
)
2
]
x
+
(
n
= 4 and 8;
x
= 10 and
18) is reported, to explore whether the R8 peptide sequence that promotes
cell uptake requires a contiguous amino acid sequence for membrane
permeation or if this can be accomplished in a linearly bridged structure
with the additive effect of shorter peptide sequences. The conjugates
exhibit NIR emission centered at 754 nm and essentially oxygen-insensitive
emission with a lifetime of 89 ns in phosphate-buffered saline. The
uptake, distribution, and cytotoxicity of the parent complex and peptide
derivatives were compared in 2D cell monolayers and a three-dimensional
(3D) multicellular tumor spheroid (MCTS) model. Whereas, the bis-octaarginine
sequences were impermeable to cells and spheroids, and the bis-tetraarginine
conjugate showed excellent cellular uptake and accumulation in two
2D monolayer cell lines and remarkable in-depth penetration of 3D
MCTSs of pancreatic cancer cells. Overall, the data indicates that
cell permeability can be promoted via non-contiguous sequences of
arginine residues bridged across the metal centre.